Cardio Diagnostics Inc. (CDIO)
Cardio Diagnostics Statistics
Share Statistics
Cardio Diagnostics has 52.15M shares outstanding. The number of shares has increased by 129.86% in one year.
| Shares Outstanding | 52.15M |
| Shares Change (YoY) | 129.86% |
| Shares Change (QoQ) | 28.95% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 48.21M |
| Failed to Deliver (FTD) Shares | 3.64K |
| FTD / Avg. Volume | 0.16% |
Short Selling Information
The latest short interest is 1.68M, so 4.15% of the outstanding shares have been sold short.
| Short Interest | 1.68M |
| Short % of Shares Out | 4.15% |
| Short % of Float | 4.6% |
| Short Ratio (days to cover) | 0.7 |
Valuation Ratios
The PE ratio is -2.67 and the forward PE ratio is -2.09. Cardio Diagnostics's PEG ratio is 0.03.
| PE Ratio | -2.67 |
| Forward PE | -2.09 |
| PS Ratio | 11074.16 |
| Forward PS | 0.7 |
| PB Ratio | 2.35 |
| P/FCF Ratio | -4.3 |
| PEG Ratio | 0.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Cardio Diagnostics.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.92, with a Debt / Equity ratio of 0.07.
| Current Ratio | 13.92 |
| Quick Ratio | 13.92 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | -0.08 |
| Debt / FCF | -0.13 |
| Interest Coverage | -448.81 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $155.69 |
| Profits Per Employee | $-644.88K |
| Employee Count | 13 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -71.9% in the last 52 weeks. The beta is 3.56, so Cardio Diagnostics's price volatility has been higher than the market average.
| Beta | 3.56 |
| 52-Week Price Change | -71.9% |
| 50-Day Moving Average | 0.47 |
| 200-Day Moving Average | 0.47 |
| Relative Strength Index (RSI) | 36.18 |
| Average Volume (20 Days) | 2.33M |
Income Statement
In the last 12 months, Cardio Diagnostics had revenue of 2.02K and earned -8.38M in profits. Earnings per share was 0.
| Revenue | 2.02K |
| Gross Profit | 2.02K |
| Operating Income | -8.37M |
| Net Income | -8.38M |
| EBITDA | -8.09M |
| EBIT | -8.36M |
| Earnings Per Share (EPS) | 0 |
Balance Sheet
The company has 7.83M in cash and 663.1K in debt, giving a net cash position of 7.16M.
| Cash & Cash Equivalents | 7.83M |
| Total Debt | 663.1K |
| Net Cash | 7.16M |
| Retained Earnings | -22.75M |
| Total Assets | 10.62M |
| Working Capital | 8.16M |
Cash Flow
In the last 12 months, operating cash flow was -4.99M and capital expenditures -214.76K, giving a free cash flow of -5.21M.
| Operating Cash Flow | -4.99M |
| Capital Expenditures | -214.76K |
| Free Cash Flow | -5.21M |
| FCF Per Share | -0.21 |
Margins
Gross margin is 100%, with operating and profit margins of -413333.84% and -414202.22%.
| Gross Margin | 100% |
| Operating Margin | -413333.84% |
| Pretax Margin | -414202.22% |
| Profit Margin | -414202.22% |
| EBITDA Margin | -399627.87% |
| EBIT Margin | -413333.84% |
| FCF Margin | -257305.78% |
Dividends & Yields
CDIO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for CDIO is $2, which is 488.2% higher than the current price. The consensus rating is "Hold".
| Price Target | $2 |
| Price Target Difference | 488.2% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
Scores
| Altman Z-Score | 5.98 |
| Piotroski F-Score | 4 |